PNA monomers fully compatible with standard Fmoc-based solid-phase synthesis of pseudocomplementary PNA

被引:9
作者
Sugiyama, Toru [1 ]
Hasegawa, Genki [1 ]
Niikura, Chie [1 ]
Kuwata, Keiko [2 ]
Imamura, Yasutada [3 ]
Demizu, Yosuke [4 ]
Kurihara, Masaaki [5 ]
Kittaka, Atsushi [1 ]
机构
[1] Teikyo Univ, Fac Pharmaceut Sci, Itabashi Ku, Tokyo 1738605, Japan
[2] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648601, Japan
[3] Kogakuin Univ, Fac Engn, 2665-1 Nakano, Hachioji, Tokyo 1920015, Japan
[4] Minist Hlth & Welf Japan, Natl Inst Hlth Sci, Div Organ Chem, Setagaya Ku, Tokyo 1588501, Japan
[5] Int Univ Hlth & Welf, Sch Pharm, 2600-1 Kitakanemaru, Ohtawara, Tochigi 3248501, Japan
基金
日本学术振兴会;
关键词
Peptide nucleic acid; Strand invasion; Pseudocomplementary; Antigene; PEPTIDE NUCLEIC-ACIDS; PSEUDO-COMPLEMENTARY PNA; DOUBLE-STRANDED DNA; DUPLEX DNA; RESTRICTION; EFFICIENT; ENZYMES;
D O I
10.1016/j.bmcl.2017.06.015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Here we report the synthesis of new PNA monomers for pseudocomplementary PNA (pcPNA) that are fully compatible with standard Fmoc chemistry. The thiocarbonyl group of the 2-thiouracil (sU) monomer was protected with the 4-methoxy-2-methybenzyl group (MMPM), while the exocyclic amino groups of diaminopurine (D) were protected with Boc groups. The newly synthesized monomers were incorporated into a 10-mer PNA oligomer using standard Fmoc chemistry for solid-phase synthesis. Oligomerization proceeded smoothly and the HPLC and MALDI-TOF MS analyses indicated that there was no remaining MMPM on the sU nucleobase. The new PNA monomers reported here would facilitate a wide range of applications, such as antigene PNAs and DNA nanotechnologies. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3337 / 3341
页数:5
相关论文
共 24 条
  • [1] Pseudo-complementary PNA actuators as reversible switches in dynamic DNA nanotechnology
    Ackermann, Damian
    Famulok, Michael
    [J]. NUCLEIC ACIDS RESEARCH, 2013, 41 (08) : 4729 - 4739
  • [2] AHSt Amant, 2012, ORG BIOMOL CHEM, V10, P876
  • [3] STABILITY OF PEPTIDE NUCLEIC-ACIDS IN HUMAN SERUM AND CELLULAR-EXTRACTS
    DEMIDOV, VV
    POTAMAN, VN
    FRANKKAMENETSKII, MD
    EGHOLM, M
    BUCHARD, O
    SONNICHSEN, SH
    NIELSEN, PE
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (06) : 1310 - 1313
  • [4] Synthesis of tert-butoxycarbonyl (Boc)-protected purines
    Dey, S
    Garner, P
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (22) : 7697 - 7699
  • [5] PNA HYBRIDIZES TO COMPLEMENTARY OLIGONUCLEOTIDES OBEYING THE WATSON-CRICK HYDROGEN-BONDING RULES
    EGHOLM, M
    BUCHARDT, O
    CHRISTENSEN, L
    BEHRENS, C
    FREIER, SM
    DRIVER, DA
    BERG, RH
    KIM, SK
    NORDEN, B
    NIELSEN, PE
    [J]. NATURE, 1993, 365 (6446) : 566 - 568
  • [6] Solution- and solid-phase parallel synthesis of 4-alkoxy-substituted pyrimidines with high molecular diversity
    Font, D
    Heras, M
    Villalgordo, JM
    [J]. JOURNAL OF COMBINATORIAL CHEMISTRY, 2003, 5 (03): : 311 - 321
  • [7] Font D, 2002, SYNTHESIS-STUTTGART, P1833
  • [8] Specific and nonspecific inhibition of transcription by DNA, PNA, and phosphorothioate promoter analog duplexes
    Hamilton, SE
    Iyer, M
    Norton, JC
    Corey, DR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (23) : 2897 - 2900
  • [9] PNA-directed triple-helix formation by N7-xanthine
    Hudson, RHE
    Goncharenko, M
    Wallman, AP
    Wojciechowski, F
    [J]. SYNLETT, 2005, (09) : 1442 - 1446
  • [10] Sequence-specific protection of duplex DNA against restriction and methylation enzymes by pseudocomplementary PNAs
    Izvolsky, KI
    Demidov, VV
    Nielsen, PE
    Frank-Kamenetskii, MD
    [J]. BIOCHEMISTRY, 2000, 39 (35) : 10908 - 10913